Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Inventory: 2022-2025

Historic Change in Inventory for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Sep 2025 value amounting to $2.5 million.

  • Rhythm Pharmaceuticals' Change in Inventory rose 28.93% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 20.54%. This contributed to the annual value of $10.1 million for FY2024, which is 77.27% up from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Change in Inventory stood at $2.5 million, which was up 611.69% from -$479,000 recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Change in Inventory ranged from a high of $4.8 million in Q4 2024 and a low of -$479,000 during Q2 2025.
  • Its 3-year average for Change in Inventory is $1.7 million, with a median of $1.6 million in 2023.
  • In the last 5 years, Rhythm Pharmaceuticals' Change in Inventory soared by 31,800.00% in 2023 and then crashed by 113.74% in 2025.
  • Quarterly analysis of 4 years shows Rhythm Pharmaceuticals' Change in Inventory stood at $1.2 million in 2022, then decreased by 29.98% to $862,000 in 2023, then soared by 462.18% to $4.8 million in 2024, then rose by 28.93% to $2.5 million in 2025.
  • Its Change in Inventory was $2.5 million in Q3 2025, compared to -$479,000 in Q2 2025 and $575,000 in Q1 2025.